UPC Court of Appeal Overturns Helsinki on Opt Out Withdrawal

Darren Smyth
January 14, 2025
#
UPC

AIM Sport v Supponor UPC_CoA_489/2023 and UPC_CoA_500/2023

Decision of 12 November 2024 (ORD_598488/2023 & ORD_598489/2023)

AIM Sport had brought both provisional injunction and infringement proceedings against Supponor in the UPC local division in Helsinki. As we reported, both these actions were dismissed because the local division considered it lacked jurisdiction, because the purported withdrawal of the opt out of the patent was invalid due to earlier German national proceedings relating to the same patent which had been commenced in 2020.

Opt out is governed by Article 83(3) of the UPC Agreement:

Unless an action has already been brought before the Court, a proprietor of or an applicant for a European patent granted or applied for prior to the end of the transitional period … shall have the possibility to opt out from the exclusive competence of the Court.

And withdrawal of opt out is governed by Article 83(4) of the UPC Agreement:

Unless an action has already been brought before a national court, proprietors of or applicants for European patents … who made use of the opt-out in accordance with [Art 83(3)] shall be entitled to withdraw their opt-out at any moment.

The determinative question was whether in Article 83(4) "already been brought before a national court" refers only to actions commenced during the transitional period, i.e. after 1 June 2023 when the UPC Agreement came into force, or would apply also to actions commenced before 1 June 2023, as in the case at hand.

The first instance court took the latter view, and accordingly held that Article 83(4) precluded withdrawal of opt out of the patent, so that the UPC had no jurisdiction over the patent.

On appeal, the Court of Appeal took the opposite view. According to the judgment, considering the wording, structure, object and purpose of Art. 83 UPCA as a whole, Article 83(4) is to be understood as referring only to an action brought before a national court during the transitional regime, and not one already pending at 1 June 2023.

Accordingly, the Court of Appeal considered that the UPC does have jurisdiction over the patent, and remitted the cases back to the same panel of the first instance Court for further adjudication.

The first instance reasoning seems more compelling in this case, and the Court of Appeal judgment lacks a convincing justification. However, the question is a difficult one to decide, since the purpose of the restriction in Article 83(4) is unclear (whereas it is evident that the restriction in Article 83(3) is to prevent the abuse of making use the UPC system and then opting out of it). The appeal ruling is likely the final word on this issue, and therefore the circumstances in which a patentee cannot validly withdraw an opt out have been significantly narrowed.

Recent Case Reports

Scripps mRNA reengineering patent found invalid and not infringed by Comirnaty
08 September 2026
The Local Division Munich invalidated Promosome's licensed mRNA patent over Scripps' codon-optimisation method, then found BioNTech's Comirnaty vaccine would not have infringed the claims even had they been valid.
Fujifilm v Kodak: clarifying the defence of dependent claims and inventive-step combinations at the UPC
27 August 2026
The Court of Appeal gave guidance on defending dependent claims, relying on EPO central limitation during UPC proceedings, and pleading revocation attacks. It also emphasised that inventive-step combinations require a proper pointer to the secondary reference.
Can Reference Numerals Influence Claim Interpretation?
21 August 2026
In T 0903/24, the EPO Board of Appeal relied on reference numerals to interpret disputed claim language, rejecting the patentee's narrower reading and revoking novelty over prior art D2 for the main request.